Occurrence and characteristics of extended spectrum beta-lactamases-producing enterobacteriaceae from foods of animal origin

Brazilian Journal of Microbiology

Volumn 47, Issue 2, 2016, Pages 444-451

  Tekiner, İsmail Hakkı ^a   Özpınar, Haydar ^a  

^a ISTANBUL AYDIN UNIVERSITY   (Turkey)

Author keywords

Bla gene; Enterobacteriaceae; ESBL; Public health; Turkey

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ANIMAL; BOVINE; CHEESE; CHICKEN; DRUG EFFECTS; ENTEROBACTERIACEAE; ENZYMOLOGY; FOOD CONTROL; GENETICS; ISOLATION AND PURIFICATION; MEAT; METABOLISM; MICROBIOLOGY; MILK; MULTIDRUG RESISTANCE; TURKEY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CATTLE; CHEESE; CHICKENS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; FOOD MICROBIOLOGY; MEAT; MILK; TURKEY;

EID: 84973101033     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1016/j.bjm.2015.11.034     Document Type: Article

References (78)

1. Wang H, McEntire JC, Zhang L, Li X, Doyle M. The transfer of antibiotic resistance from food to humans: facts, implications and future directions. Rev Sci Tech.2012;31:249–260.
2. Thenmozhi S, Moorthy K, Sureshkumar BT, Suresh M. Antibiotic resistance mechanism of ESBL producing Enterobacteriaceae in clinical field: a review. Int J Pure ApplBiosci. 2014;2:207–226.
3. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases:a clinical update. Clin Microbiol Rev. 2005;18:657–686.
4. Rupp ME, Fey PD. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs.2003;63:353–365.
5. EFSA. Scientific opinion on the public health risks ofbacterial strains producing extended-spectrum β-lactamasesand/or AmpC β-lactamases in food and food-producing animals. EFSA J. 2011;9:2322–2417.
6. Liebana E, Carattoli A, Coque TM, et al. Public health risks of enterobacterial isolates producing extended-spectrum β lactamases or AmpC β-lactamases in food andfood-producing animals: an EU perspective of epidemiology, analytical methods, risk factors, and control options. ClinInfect Dis. 2013;56:1030–1037.
7. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother. 2004;48:1–14.
8. Fernandes R, Amador P, Oliveira C, Prudêncio C. Molecular characterization of ESBL-producing Enterobacteriaceae in Northern Portugal. Sci World J. 2014;2014:782897, http://dx.doi.org/10.1155/2014/782897.
9. Giedraitienė A, Vitkauskienė A, Naginienė R, Pavilonis A. Antibiotic resistance mechanisms of clinically importantbacteria. Medicina (Kaunas). 2011;47:137–146.
10. Mesa RJ, Blanc V, Blanch AR, et al. Extended-spectrum β-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage). JAntimicrob Chemother. 2006;58:211–215.
11. Reuland EA, al Naiemi N, Raadsen SA, Savelkoul PHM, Kluytmans JAJW, Vandenbroucke-Grauls CMJE. Prevalence of ESBL-producing Enterobacteriaceae in raw vegetables. Eur JClin Microbiol Infect Dis. 2014;33:1843–2184.
12. Ghafourian S, Sadeghifard N, Soheili S, Sekawi Z. Extendedspectrum beta-lactamases: definition, classification andepidemiology. Curr Issues Mol Biol. 2014;17:11–22.
13. von Salviati C, Laube H, Guerra B, Roesler U, Friese A. Emission of ESBL/AmpC-producing Escherichia coli from pigfattening farms to surrounding areas. Vet Microbiol.2015;175:77–84.
14. Habeeb MA, Sarwar Y, Ali A, Salman M, Haque A. Rapidemergence of ESBL producers in E. coli causing urinary andwound infections in Pakistan. Pak J Med Sci. 2013;29:540–544.
15. Sharma M, Pathak S, Srivastava P. Prevalence and antibiogram of extended spectrum _-lactamase (ESBL) producing Gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp. J Clin Diagn Res. 2013;7:2173–2177.
16. WHO. Integrated surveillance of antimicrobial resistance:guidance from a WHO Advisory Group; 2013 ISBN 978 92 4150631 1, Switzerland.
17. Laxminarayan R, Duse A, Wattal C, et al. Antibioticresistance – the need for global solutions. Lancet Infect Dis.2013;13:1057–1098.
18. Capita R, Alonso-Calleja C. Antibiotic-resistant bacteria: a challenge for the food industry. Crit Rev Food Sci.2013;53:11–48.
19. Arslan S, Özdemir F. Extended spectrum beta-lactamases in Escherichia coli strains isolated from homemade white cheeses: prevalence and antibiotics susceptibility. World JMicrobiol Biotechnol. 2008;24:2361–2364.
20. Yıbar A, Soyutemiz E. Antibiotics use in food-producing animals and possible residual risk. Atatürk Üniversitesi Vet Bil Derg. 2013;8:97–104.
21. Geser N, Stephan R, Hächler H. Occurrence and characteristics of extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae in food producing animals, minced meat and raw milk. BMC Vet Res. 2013;8:21.
22. CLSI. Performance standards for antimicrobial susceptibility testing. Twenty-Third Informational Supplement. CLSI Document;2013. M100-S23.
23. Ojdana D, Sacha PB, Wieczorek P, et al. The occurrence of bla CTX-M, bla SHV, and bla TEM genes in extended-spectrum β-lactamase-positive strains of Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in Poland. Int J Antibiot.2014;2014:935842.
24. Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapiddetection of genes encoding CTX-M extended-spectrumb-lactamases. J Antimicrob Chemother. 2006;57:154–155.
25. Haque A, Yoshizumi A, Saga T, Ishii Y, Tateda K.ESBL-producing Enterobacteriaceae in environmental waterin Dhaka, Bangladesh. J Infect Chemother. 2014;20:735–737.
26. Mitchell SM, Subbiah M, Ullman JL, Frear C, Call DR. Evaluation of 27 different biochars for potentialsequestration of antibiotic residues in food animal production environments. J Environ Chem Eng. 2015;3:162–169.
27. Allen HK, Donato J, Wang HH, Cloud-Hansen KA, Davies J, Handelsman J. Call of the wild: antibiotic resistance genes in natural environments. Nat Rev Microbiol. 2010;8:251–259.
28. Lupo A, Papp-Wallace KM, Sendi P, Bonomo RA, Endimiani A. Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae. DiagnMicrobiol Infect Dis. 2013;77:179–194.
29. Stefani S, Giovanelli I, Anacarso I, et al. Prevalence and characterization of extended-spectrum β-lactamase-producing Enterobacteriaceae in food-producing animals in Northern Italy. New Microbiol.2014;37:551–555.
30. Bonelli RR, Moreira BM, Picão RC. Antimicrobial resistanceamong Enterobacteriaceae in South America: history, current dissemination status and associated socioeconomic factors. Drug Resist Update. 2014;17:24–36.
31. Overdevest I, Willemsen I, Rijnsburger M, et al. Extended-spectrum beta-lactamase genes of Escherichia coliin chicken meat and humans, The Netherlands. Emerg InfectDis. 2011;17:1216–1222.
32. Doyle MP, Loneragan GH, Scott HM, Singer RS. Antimicrobialresistance: challenges and perspectives. Compr Rev Food Sci Foof Saf. 2013;12:234–248.
33. Aidara-Kane A, Andremont A, Collignon P. Antimicrobialresistance in the food chain and the AGISAR initiative. J InfectPublic Health. 2013;6:162–165.
34. Lahlaoui H, Ben Haj Khalifa A, Ben Moussa M. Epidemiology of Enterobacteriaceae producing CTX-M type extended spectrum β-lactamase (ESBL). Méd Maladies Infect.2014;44:400–404.
35. Rao L, Lv L, Zeng Z, et al. Increasing prevalence of extended-spectrum cephalosporin-resistant Escherichia coliin food animals and the diversity of CTX-M genotypes during 2003–2012. Vet Microbiol. 2014;172:534–541.
36. Su Y, Yu CY, Tsai Y, Wang SH, Lee C, Chu C. Fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli from the milk of cowswith clinical mastitis in Southern Taiwan. J Microbiol ImmunolInfect. 2014, http://dx.doi.org/10.1016/j.jmii.2014.10.003.
37. Melzera M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase(ESBL) producing E. coli compared to non-ESBL producing E.coli. J Infect. 2007;55:254–259.
38. Amador P, Fernandes R, Prudêncio C, Brito L. Resistance to β-lactams in bacteria isolated from different types of Portuguese cheese. Int J Mol Sci. 2009;10:1538–1551.
39. Garcia-Migura L, Hendriksen RS, Fraile L, Aarestrup FM. Antimicrobial resistance of zoonotic and commensal bacteria in Europe: the missing link between consumptionand resistance in veterinary medicine. Vet Microbiol.2014;170:1–9.
40. Kar D, Bandyopadhyay S, Bhattacharyya D, et al. Molecular and phylogenetic characterization of multidrug resistantextended spectrum beta-lactamase producing Escherichia coliisolated from poultry and cattle in Odisha, India. Infect GenetEvol. 2015;29:82–90.
41. Zheng H, Zeng Z, Chen S, et al. Prevalence and characterisation of CTX-M _-lactamases amongst Escherichiacoli isolates from healthy food animals in China. Int JAntimicrob Agents. 2012;39:305–310.
42. Schwaiger K, Huther S, Hölzel C, Kämpf P, Bauer J. Prevalenceof antibiotic-resistant Enterobacteriaceae isolated from chicken and pork meat purchased at the slaughterhouse andat retail in Bavaria, Germany. Int J Food Microbiol.2012;154:206–211.
43. Smet A, Martel A, Persoons D, et al. Diversity ofextended-spectrum beta-lactamases and class Cbeta-lactamases among cloacal Escherichia coli isolates in Belgian broiler farms. Antimicrob Agents Chemother.2008;52:1238–1243.
44. Petternel C, Galler H, Zarfel G, et al. Isolation and characterization of multidrug-resistant bacteria fromminced meat in Austria. Food Microbiol. 2014;44:41–46.
45. Garrec H, Drieux-Rouzet L, Golmard JL, Jarlier V, Robert J. Comparison of nine phenotypic methods for detection of extended-spectrum β-lactamase Production by Enterobacteriaceae. J Clin Microbiol. 2011;49:1048–1057.
46. Perez F, Endimiani A, Hujer KM, Bonomo RA. The continuing challenge of ESBLs. Curr Opin Pharmacol. 2007;7:459–469.
47. Naas T, Oxacelay C, Nordmann P. Identification of CTX-M-Type extended-spectrum- _-lactamase genes usingreal-time PCR and pyrosequencing. Antimicrob AgentsChemother. 2007;51:223–230.
48. Bradford PA. Extended-spectrum β-lactamases in the 21stcentury: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev.2001;14:933–951.
49. Srisangkaew S, Vorachit M. The optimum agent for screeningand confirmatory tests for extended-spectrumbeta-lactamases in Escherichia coli and Klebsiella pneumoniaein Ramathibodi Hospital, Thailand. J Infect Dis AntimicrobAgents. 2004;21:1–5.
50. Taneja N, Sharma M. ESBL detection in clinical microbiology:why & how? Indian J Med Res. 2008;127:297–300.
51. Thomson KS. Extended-spectrum- β-lactamase, Amp C, and carbapenemase issues. J Clin Microbiol. 2010;48:1019–1025.
52. Turner PJ. MYSTIC Europe 2007: activity of meropenem andother broad-spectrum agents against nosocomial isolates. Diagn Microbiol Infect Dis. 2009;63:217–222.
53. Korten V, Ulusoy S, Zarakolu P, Mete B, Turkish MYSTIC StudyGroup. Antibiotic resistance surveillance over a 4-year period (2000–2003) in Turkey: results of the MYSTIC program. DiagnMicrobiol Infect Dis. 2007;59:453–457.
54. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediatedAmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40:2153–2162.
55. Kiratisin P, Henprasert A. Genotypic analysis of plasmid-mediated beta-lactamases amongstEnterobacteriaceae other than Escherichia spp. and Klebsiell aspp. that are non-susceptible to a broad-spectrumcephalosporin. Int J Antimicrob Agents. 2010;36:343–347.
56. Thomson KS. Controversies about extended-spectrum andAmpC beta-lactamases. Emerg Infect Dis. 2001;7:333–336.
57. Jacoby GA. Amp C beta-lactamases. Clin Microbiol Rev.2009;22:161–182.
58. Nazik H, Bektore B, Ongen B, et al. Plasmid-mediatedquinolone resistance genes in Escherichia coli urinary isolatesfrom two teaching hospitals in Turkey: coexistence of TEM,SHV, CTX-M and VEB-1 Type β-lactamases. Trop J Pharm Res.2011;10:325–333.
59. Zaniani FR, Meshkat Z, Nasab MN, et al. The prevalence of TEM and SHV genes among extended-spectrumbetalactamases producing Escherichia coli and Klebsiellapneumoniae. Iran J Basic Med Sci. 2012;15:654–660.
60. Ferreira JC, Filho RACP, Andrade LN, Junior AB, Darini ALC.IncI1/ST113 and IncI1/ST114 conjugative plasmids carryingblaCTX-M-8 in Escherichia coli isolated from poultry in Brazil. Diagn Microbiol Infect Dis. 2014;80:304–306.
61. Chouchani C, Marrakchi R, El Salabi A. Evolution of β-lactams resistance in Gram-negative bacteria in Tunisia.Crit Rev Microbiol. 2011;37:167–177.
62. Hiroi M, Yamazaki F, Harada T, et al. Prevalence of extended-spectrum β-lactamase-producing Escherichia coliand Klebsiella pneumoniae in food-producing animals. J VetMed Sci. 2012;74:189–195.
63. Kawamura K, Goto K, Nakane K, Arakawa Y. Molecular epidemiology of extended-spectrum β-lactamases and Escherichia coli isolated from retail foods including chickenmeat in Japan. Foodborne Pathog Dis. 2014;11:104–110.
64. Reich F, Atanassova V, Klein G. Extended-spectrum β-lactamase- and Amp C-producing enterobacteria inhealthy broiler chickens, Germany. Emerg Infect Dis.2013;19:1253–1259.
65. Zarfel G, Galler H, Luxner J, et al. multiresistant bacteriaisolated from chicken meat in Austria. Int J Environ Res Public Health. 2014;11:12582–12593.
66. Randall L, Heinrich K, Horton R, et al. Detection of antibiotic residues and association of cefquinome residues with the occurrence of extended-spectrum β-Lactamase (ESBL)-producing bacteria in waste milk samples from dairy farms in England and Wales in2011. Res Vet Sci.2014;96:15–24.
67. Khoshbakht R, Shahed A, Aski HS. Characterization of extended spectrum B-lactamase-producing Escherichiae colisrains isolated from dairy products. J Microbiol Biotechnol FoodSci. 2014; 3:333–336.
68. Ahmed AM, Shimamoto T. Molecular analysis of multidrug resistance in Shiga toxin-producing Escherichia coli O157:H7isolated from meat and dairy products. Int J Food Microbiol.2015;193:68–73.
69. Gundogan N, Yakar U. Siderophore production, serumresistance, hemolytic activity and extended spectrum beta lacta mase producing Klebsiella species isolated from milkand milk products. J Food Saf. 2007;3:251–260.
70. Gundogan N, Cıtak S, Yalcin E. Virulence properties ofextended spectrum beta-lactamase-producing Klebsiella species in meat samples. J Food Prot. 2011;74:559–564.
71. Gundogan N, Avci E. Prevalence and antibiotic resistance ofextended spectrum beta-lactamase (ESBL) producing Escherichia coli and Klebsiella species isolated from foods ofanimal origin in Turkey. Afr J Microbiol Res. 2013;7:4059–4064.
72. Cantón R, González-Alba JM, Galán JC. CTX-M enzymes:origin and diffusion. Front Microbiol. 2012;3:110.
73. Priyadharsini RI, Kavitha A, Rajan R, Mathavi S, Rajesh KR. Prevalence of bla CTX M extended spectrum beta lactamasegene in Enterobacteriaceae from critical care patients. J LabPhysicians. 2011;3:80–83.
74. Hawkey PM. Multidrug-resistant Gram-negative bacteria: aproduct of globalization. J Hosp Infect. 2015;89:241–247.
75. Rossolini GM, D’Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum β-lactamases. Clin MicrobiolInfect. 2008;14:33–41.
76. Gonullu N, Aktas Z, Kayacan CB, et al. Dissemination ofCTX-M-15 β-lactamase genes carried on Inc FI and FIIplasmids among clinical isolates of Escherichia coli in a University Hospital in Istanbul, Turkey. J Clin Microbiol.2008;46:1110–1112.
77. Vankerckhoven V, Huys G, Vancanneyt M, et al. Biosafety assessment of probiotics used for human consumption:recommendations from the EU-PROSAFE Project. Trends FoodSci Technol. 2008;19:102–114.
78. Sharma P, Tomar SK, Goswami P, Sangwan V, Singh R. Antibiotic resistance among commercially available probiotics. Food Res Int. 2014;57:176–195.